Clinical Trial

Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease

Study acronym: FAVORIT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn how enzyme replacement therapy works in patients with Fabry disease. The main question it aims to answer is: What medical problems do participants have? Participants already on enzyme replacement therapy as part of their regular medical care for Fabry disease will be observed as usual. Their data will be collected by their doctor.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-11.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-24
Trial Details
NCT Number NCT06880250
Lead Sponsor NPO Petrovax
Conditions Fabry Disease
Enrollment 100 participants
Start Date 2025-03-24
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-31